Serum GlycA Level is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity

Reliable non-invasive biomarkers are needed to assess disease activity and prognosis in patients with systemic lupus erythematosus (SLE). Glycoprotein acetylation (GlycA), a novel biomarker for chronic inflammation, has been reported to be increased in several inflammatory diseases. We investigated...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical medicine Vol. 9; no. 4; p. 970
Main Authors:	Dierckx, Tim, Chiche, Laurent, Daniel, Laurent, Lauwerys, Bernard, Weyenbergh, Johan Van, Jourde-Chiche, Noémie
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 31-03-2020 MDPI
Subjects:	Biomarkers Biopsy Cholesterol Classification Clinical medicine Creatinine Drug dosages Gene expression Glycoproteins High density lipoprotein Human health and pathology Kidney diseases Life Sciences Lupus Mortality Neutrophils NMR Nuclear magnetic resonance Spectrum analysis Statistical analysis Values Variables Belgium disease activity systemic chronic inflammation systemic lupus erythematosus lupus nephritis severity glycoprotein acetylation
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!